Congress of Clinical Rheumatology

Oakstone Clinical Update

Discover new cutting edge advancements and emerging issues in the evaluation and treatment of rheumatic disorders and diseases. Ideal for MOC.

If your primary viewing mode will be on a computer or tablet, we recommend the Online Video package. In addition to online access, you will receive a USB with MP4 files. Use the USB to watch offline or import into iTunes and other media players and then synch to your mobile device, laptop or desktop. Plus you save $130 including standard shipping charges vs the DVD package.

  • Audio MP3s
  • Combo
SKU: 120

Discover New Guidelines

Intended for practicing and training clinical rheumatologists, this course features recorded lectures from America’s premier independent rheumatology symposium. It features unbiased content so you may confidently incorporate the latest into your practice including knowledge of:

  • The latest treatment guidelines and therapies for lupus nephritis, fibromyalgia, sarcoidosis, schleroderma, osteoporosis, psoriatic arthritis, Behcet’s Syndrome and other conditions
  • Possible therapeutic interventions for various types of pain associated with rheumatic disease
  • The latest research on interstitial lung disease and bone erosion in rheumatoid arthritis

Convenient Home Study Update

A clinically based update from thought leaders in rheumatology, this course provides a maximum of 23 AMA PRA Category 1 Credits and 23 ABIM MOC points and offers online or audio MP3 CD formats enabling you to learn at your own ... whether at home or in the office.

View our full list of Topics/Speakers, Faculty, Accreditation and Media Format information.

  • Sequential/Combination Therapy in Osteoporosis - Felicia Cosman, MD
  • Treatment to Goal in Osteoporosis - Felicia Cosman, MD
  • Regulation of Bone Homeostasis: Signaling Pathways and Novel Targets - David W. Dempster, PhD, FRMS
  • CCR Thieves' Market - Alan Epstein, MD, Moderator
  • What's New in Spinal Osteoarthritis? - Alfred C. Gellhorn, MD
  • Cryoglobulinemia - Peter Gorevic, MD
  • Joint Hypermobility Syndrome - An Evolving Multi-System Disorder - Rodney Grahame, CBE, MD, FRCP, FACP
  • Management of the Joint Hypermobility Syndrome - Rodney Grahame, CBE, MD, FRCP, FACP
  • Disease Activity Measurement and Biomarkers in RA - Max Hamburger, MD
  • Current Legislative & Regulatory Issues Facing Rheumatologists - Robert S. Jasak, JD
  • Gout Update - Robert Keenan, MD, MPH
  • Inflammatory Eye Diseases in the Rheumatic Disease Patient - Robert Keenan, MD, MPH
  • Inclusion Body Myositis - Thomas Lloyd, MD, PhD
  • Antiphospholipid Antibody Syndrome Update - Michelle Petri, MD, MPH
  • Lupus Update 2014 - Michelle Petri, MD, MPH
  • Central Pain Mechanisms in the Rheumatic Diseases - Kristine Phillips, MD, PhD
  • ASIA: Autoimmune/Autoinflammatory Syndrome – Induced by Adjuvants and Autoimmune Rheumatic Diseases, 2014 - Yehuda Shoenfeld, MD, FRCP
  • Infections and Autoimmunity – How Can We Harness Nature to Treat Autoimmune Diseases? - Yehuda Shoenfeld, MD, FRCP
  • To D or Not to D? - This is the Question - Yehuda Shoenfeld, MD, FRCP
  • Clinical Cases in Rheumatology-Dermatology - Ruth Ann Vleugels, MD, MPH
  • Connective Tissue Disease and Dermatology: Cutaneous Lupus, Dermatomyositis and Scleroderma - Ruth Ann Vleugels, MD, MPH
  • Scleroderma - Evidence of a Vascular Disease - Fredrick Wigley, MD
  • Vascular Treat to Target - Possible Strategy in Scleroderma? - Fredrick Wigley, MD
  • Behçet's Syndrome: Update 2014 - Yusuf Yazici, MD


Felicia Cosman, MD

  • Clinical Professor, Department of Pathology
  • The University of Texas MD Anderson Cancer Center
  • Cedars-Sinai Medical Center
  • Los Angeles, CA
  • Baylor University
  • Dallas, TX

David W. Dempster, PhD, FRMS

  • Professor of Clinical Pathology & Cell Biology
  • College of Physicians & Surgeons
  • Columbia University, NY
  • Director Emeritus, Regional Bone Center
  • Helen Hayes Hospital
  • New York State Department of Health

Alan Epstein, MD

  • Associate Professor of Medicine
  • Division of Rheumatology
  • University of Pennsylvania School of Medicine
  • Philadelphia, PA

Alfred Gellhorn, MD

  • Clinical Assistant Professor
  • Department of Rehabilitation Medicine
  • University of Washington School of Medicine
  • Seattle, WA

Peter Gorevic, MD

  • Professor of Medicine
  • Mount Sinai School of Medicine
  • New York, NY

Rodney Grahame, CBE, MD, FRCP, FACP

  • Honorary Professor
  • Center for Rheumatology
  • University College London Hospitals
  • London, England

Max Hamburger, MD

  • Managing Partner, Rheumatology Associates of Long Island
  • Assistant Professor of Clinical Medicine, SUNY Stony Brook
  • President, New York State Rheumatology Society
  • President, American Society of Clinical Rheumatologists
  • Melville, NY

Robert S. Jasak, JD

  • Vice President
  • Coverage & Payment Policy
  • Hart Health Strategies
  • Washington, DC


Robert Keenan, MD, MPH

  • Assistant Professor of Medicine
  • Duke University School of Medicine
  • Durham, NC

Thomas Lloyd, MD, PhD

  • Assistant Professor
  • Department of Neurology and Neuroscience
  • Johns Hopkins University School of Medicine
  • Baltimore, MD

Michelle, Petri, MD, MPH

  • Professor of Medicine
  • Director, Lupus Center
  • Johns Hopkins University School of Medicine
  • Baltimore, MD

Kristine Phillips, MD, PhD

  • Associate Professor
  • Division of Rheumatology
  • University of Michigan Medical School
  • Ann Arbor, MI

Yehuda Shoenfeld, MD, FRCP

  • Head, Zabludowicz Center for Autoimmune Diseases
  • Incumbent of Laura Schwartz-Kipp Research Chair in
  • Autoimmune Diseases
  • Tel Aviv University Sackler Faculty of Medicine
  • Tel-Hashomer, Israel

Ruth Ann Vleugels, MD, MPH

  • Assistant Professor of Dermatology
  • Harvard Medical School
  • Director, Autoimmune Skin Disease Program
  • Brigham & Women's Hospital
  • Boston, MA

Fredrick Wigley, MD

  • Professor of Medicine
  • Associate Director, Division of Rheumatology
  • Director, Johns Hopkins Scleroderma Center
  • Johns Hopkins University School of Medicine
  • Boston, MA

Yusuf Yazici, MD

  • Assistant Professor
  • Director, Seligman Center for Advanced Therapeutics & Behçet's Syndrome Center
  • New York University School of Medicine
  • New York, NY


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and A&R Education Group LLC. Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.


Oakstone Publishing, LLC designates this enduring material for a maximum of 23 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 23 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Date of Original Release: January 15, 2015
Credit Expiration Date: January 15, 2018
Estimated Time to Complete: 23 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

Learning Objectives

After viewing this activity, participants should be able to affirm or modify their approach to patient management in the following areas:

  • Discuss the reasons why Mixed Connective Tissue Disease is not really mixed.
  • Predict brain changes in the first month of daily opioid therapy and review implications for addiction and hyperalgesia.
  • Evaluate the evidence and discussions that were used to generate the ACR treatment guidelines for lupus nephritis and assess new SLE therapies.
  • Identify the features of IgG4-related disease.
  • Assess mechanisms and prevention approaches for accelerated atherosclerosis in SLE.
  • Describe the current state of the art treatment of ANCA-associated vasculitis.
  • Define new mechanisms involved in the development of osteoarthritis.
  • Illustrate the complex relationship between chronic kidney disease and bone disease in adults.
  • Summarize the current concepts of low dose naltrexone in the treatment of fibromyalgia.
  • Name the advances in the pathogenesis and treatment of sarcoidosis.
  • Evaluate the latest research on the effect of arthritis on bone and cartilage.
  • Appraise imaging of the immune system.
  • List the legislative and regulatory issues facing rheumatologists.
  • Formulate a treatment plan for scleroderma manifestations.
  • Assess complementary and alternative medicine as it applies to rheumatology.
  • Identify the clinical rheumatology questions that have been answered in the laboratory.
  • List the therapeutic options available for psoriatic arthritis.
  • Recall the latest data on myopathies from pathogeny to treatment.
  • Summarize the news on bone erosion in rheumatoid arthritis.
  • Discuss the latest research on interstitial lung disease.
  • Identify the rheumatic manifestations of cancer.
  • Describe unusual rheumatology cases and unusual presentations of common rheumatologic conditions as presented in the thieves’ market.
  • Assess the translational science journey that was involved with glucocorticoid--induced osteoporosis.
  • Compare combination treatment regimens in osteoporosis.

Intended Audience

Although intended primarily for clinical rheumatologists, the Congress of Clinical Rheumatology is also of great interest and value to physicians or other health care personnel who are directly involved in the care and management of rheumatic disease patients.